{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:23:38Z","timestamp":1792790618251,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-025-03180-2","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T01:51:58Z","timestamp":1736128318000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy, safety and dose patterns of tranexamic acid in meningioma surgery: a systematic review and updated meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4544-1363","authenticated-orcid":false,"given":"Lucim\u00e1rio","family":"de Carvalho Barros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4473-7148","authenticated-orcid":false,"given":"Clarissa","family":"Avancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9433-6482","authenticated-orcid":false,"given":"Paulo Eduardo","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5165-7040","authenticated-orcid":false,"given":"Wellingson Silva","family":"Paiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9651-3713","authenticated-orcid":false,"given":"Ricardo Queiroz","family":"Gurgel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4413-592X","authenticated-orcid":false,"given":"Arthur Maynart Pereira","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"key":"3180_CR1","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1093\/neuonc\/noab200","volume":"23","author":"QT Ostrom","year":"2021","unstructured":"Ostrom QT, Cioffi G, Waite K et al (2021) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014\u20132018. Neurooncology 23:iii1\u2013iii105. https:\/\/doi.org\/10.1093\/neuonc\/noab200","journal-title":"Neurooncology"},{"key":"3180_CR2","doi-asserted-by":"publisher","unstructured":"Garcia C, Slone S, Dolecek T et al (2019) Primary brain and Central Nervous System Tumor Treatment and Survival in the United States, 2004\u20132014 (S30.004). https:\/\/doi.org\/10.1212\/wnl.92.15_supplement.s30.004. Neurology 92:","DOI":"10.1212\/wnl.92.15_supplement.s30.004"},{"key":"3180_CR3","doi-asserted-by":"publisher","unstructured":"Maggio I, Franceschi E, Tosoni A et al (2021) Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas. CNS Oncol 10. https:\/\/doi.org\/10.2217\/cns-2021-0003","DOI":"10.2217\/cns-2021-0003"},{"key":"3180_CR4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.wneu.2019.02.223","volume":"128","author":"L Chen","year":"2019","unstructured":"Chen L, Li D, Lu Y et al (2019) Preoperative embolization Versus Direct surgery of meningiomas: a Meta-analysis. World Neurosurg 128:62\u201368. https:\/\/doi.org\/10.1016\/j.wneu.2019.02.223","journal-title":"World Neurosurg"},{"key":"3180_CR5","doi-asserted-by":"publisher","first-page":"4376","DOI":"10.1002\/cncr.29639","volume":"121","author":"AA Aizer","year":"2015","unstructured":"Aizer AA, Bi WL, Kandola MS et al (2015) Extent of resection and overall survival for patients with atypical and malignant meningioma. Cancer 121:4376\u20134381. https:\/\/doi.org\/10.1002\/cncr.29639","journal-title":"Cancer"},{"key":"3180_CR6","doi-asserted-by":"publisher","unstructured":"Moreau JT, Hankinson TC, Baillet S, Dudley RWR (2020) Individual-patient prediction of meningioma malignancy and survival using the Surveillance, Epidemiology, and end results database. https:\/\/doi.org\/10.1038\/s41746-020-0219-5. npj Digital Medicine 3:","DOI":"10.1038\/s41746-020-0219-5"},{"key":"3180_CR7","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s10143-010-0304-3","volume":"34","author":"MA Seifman","year":"2011","unstructured":"Seifman MA, Lewis PM, Rosenfeld JV, Hwang PYK (2011) Postoperative intracranial haemorrhage: a review. Neurosurg Rev 34:393\u2013407. https:\/\/doi.org\/10.1007\/s10143-010-0304-3","journal-title":"Neurosurg Rev"},{"key":"3180_CR8","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s10143-017-0819-y","volume":"40","author":"JA Cohen","year":"2017","unstructured":"Cohen JA, Alan N, Seicean A, Weil RJ (2017) Risk associated with perioperative red blood cell transfusion in cranial surgery. Neurosurg Rev 40:633\u2013642. https:\/\/doi.org\/10.1007\/s10143-017-0819-y","journal-title":"Neurosurg Rev"},{"key":"3180_CR9","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1055\/s-0039-3399487","volume":"10","author":"V Rajagopalan","year":"2019","unstructured":"Rajagopalan V, Chouhan RS, Pandia MP et al (2019) Effect of intraoperative blood loss on Perioperative complications and neurological outcome in adult patients undergoing elective brain tumor surgery. J Neurosciences Rural Pract 10:631\u2013640. https:\/\/doi.org\/10.1055\/s-0039-3399487","journal-title":"J Neurosciences Rural Pract"},{"key":"3180_CR10","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jocn.2017.02.053","volume":"41","author":"B Hooda","year":"2017","unstructured":"Hooda B, Chouhan RS, Rath GP et al (2017) Effect of tranexamic acid on intraoperative blood loss and transfusion requirements in patients undergoing excision of intracranial meningioma. J Clin Neurosci 41:132\u2013138. https:\/\/doi.org\/10.1016\/j.jocn.2017.02.053","journal-title":"J Clin Neurosci"},{"key":"3180_CR11","doi-asserted-by":"publisher","unstructured":"Prudovsky I, Kacer D, Zucco VV et al (2022) Tranexamic acid: beyond antifibrinolysis. Transfusion 62. https:\/\/doi.org\/10.1111\/trf.16976","DOI":"10.1111\/trf.16976"},{"key":"3180_CR12","doi-asserted-by":"publisher","unstructured":"(2019) Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet 394:1713\u20131723. https:\/\/doi.org\/10.1016\/s0140-6736(19)32233-0","DOI":"10.1016\/s0140-6736(19)32233-0"},{"key":"3180_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.wneu.2022.07.044","volume":"166","author":"Z-G Liu","year":"2022","unstructured":"Liu Z-G, Yang F, Zhu Y-H et al (2022) Is Tranexamic Acid Beneficial in Open spine surgery? And its effects Vary by Dosage, Age, sites, and locations: a Meta-analysis of Randomized controlled trials. World Neurosurg 166:141\u2013152. https:\/\/doi.org\/10.1016\/j.wneu.2022.07.044","journal-title":"World Neurosurg"},{"key":"3180_CR14","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jemermed.2018.06.025","volume":"55","author":"A Baehr","year":"2018","unstructured":"Baehr A (2018) Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomized, placebo-controlled, phase 3 superiority trial. J Emerg Med 55:298. https:\/\/doi.org\/10.1016\/j.jemermed.2018.06.025","journal-title":"J Emerg Med"},{"key":"3180_CR15","doi-asserted-by":"publisher","first-page":"101195","DOI":"10.1016\/j.bas.2022.101195","volume":"2","author":"M Germans","year":"2022","unstructured":"Germans M, Dronkers W, Baharoglu M et al (2022) Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Brain Spine 2:101195. https:\/\/doi.org\/10.1016\/j.bas.2022.101195","journal-title":"Brain Spine"},{"key":"3180_CR16","doi-asserted-by":"publisher","first-page":"e5021","DOI":"10.1097\/gox.0000000000005021","volume":"11","author":"A Alabdulkarim","year":"2023","unstructured":"Alabdulkarim A, Al Qurashi AA, Odeh NB et al (2023) Effect of Tranexamic Acid on the reduction of blood loss in craniosynostosis surgery: a systematic review and Meta-analysis. Plast Reconstr Surg - Global Open 11:e5021. https:\/\/doi.org\/10.1097\/gox.0000000000005021","journal-title":"Plast Reconstr Surg - Global Open"},{"key":"3180_CR17","doi-asserted-by":"publisher","first-page":"272","DOI":"10.25259\/sni_296_2021","volume":"12","author":"GK Ravi","year":"2021","unstructured":"Ravi GK, Panda N, Ahluwalia J et al (2021) Effect of tranexamic acid on blood loss, coagulation profile, and quality of surgical field in intracranial meningioma resection: a prospective randomized, double-blind, placebo-controlled study. Surg Neurol Int 12:272. https:\/\/doi.org\/10.25259\/sni_296_2021","journal-title":"Surg Neurol Int"},{"key":"3180_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.25259\/sni_177_2021","volume":"12","author":"L Rebai","year":"2021","unstructured":"Rebai L, Mahfoudhi N, Fitouhi N et al (2021) Intraoperative tranexamic acid use in patients undergoing excision of intracranial meningioma: Randomized, placebo-controlled trial. Surg Neurol Int 12:289. https:\/\/doi.org\/10.25259\/sni_177_2021","journal-title":"Surg Neurol Int"},{"key":"3180_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jocn.2023.01.012","volume":"110","author":"AL Clynch","year":"2023","unstructured":"Clynch AL, Gillespie CS, Richardson GE et al (2023) Tranexamic acid use in meningioma surgery \u2013 A systematic review and meta-analysis. J Clin Neurosci 110:53\u201360. https:\/\/doi.org\/10.1016\/j.jocn.2023.01.012","journal-title":"J Clin Neurosci"},{"key":"3180_CR20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s11060-023-04237-2","volume":"161","author":"JH Wijaya","year":"2023","unstructured":"Wijaya JH, July J, Quintero-Consuegra M, Chadid DP (2023) A systematic review and meta-analysis of the effects of tranexamic acid in surgical procedure for intracranial meningioma. J Neurooncol 161:383\u2013393. https:\/\/doi.org\/10.1007\/s11060-023-04237-2","journal-title":"J Neurooncol"},{"key":"3180_CR21","doi-asserted-by":"publisher","first-page":"654","DOI":"10.36552\/pjns.v26i4.822","volume":"26","author":"U Adnan Khalid","year":"2023","unstructured":"Adnan Khalid U, Nazir N, Raza et al (2023) A comparison of the Use of Tranexamic Acid versus Placebo in patients undergoing excision of Intracranial Meningioma. Pakistan J Neurol Surg 26:654\u2013666. https:\/\/doi.org\/10.36552\/pjns.v26i4.822","journal-title":"Pakistan J Neurol Surg"},{"key":"3180_CR22","doi-asserted-by":"publisher","first-page":"111285","DOI":"10.1016\/j.jclinane.2023.111285","volume":"92","author":"S Li","year":"2024","unstructured":"Li S, Liu M, Yang J et al (2024) Intravenous tranexamic acid for intracerebral meningioma resections: a randomized, parallel-group, non-inferiority trial. J Clin Anesth 92:111285. https:\/\/doi.org\/10.1016\/j.jclinane.2023.111285","journal-title":"J Clin Anesth"},{"key":"3180_CR23","doi-asserted-by":"publisher","unstructured":"Li T, Higgins JP, Deeks JJ (2019) Collecting data. Cochrane Handb Syst Reviews Interventions 109\u2013141. https:\/\/doi.org\/10.1002\/9781119536604.ch5","DOI":"10.1002\/9781119536604.ch5"},{"key":"3180_CR24","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie J, Bossuyt P et al (2020) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Center for Open Science","DOI":"10.31222\/osf.io\/v7gm2"},{"key":"3180_CR25","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, Gotzsche PC et al (2011) The Cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:d5928\u2013d5928. https:\/\/doi.org\/10.1136\/bmj.d5928","journal-title":"BMJ"},{"key":"3180_CR26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.24244\/jni.vol8i1.200","volume":"8","author":"S Sutanto","year":"2019","unstructured":"Sutanto S, Yulianti Bisri D, Bisri T (2019) Pengaruh Asam Traneksamat Intravena terhadap Jumlah Perdarahan Intraoperatif Dan Kebutuhan Transfusi Pada Operasi Meningioma. Jurnal Neuroanestesi Indonesia 8:8\u201316. https:\/\/doi.org\/10.24244\/jni.vol8i1.200","journal-title":"Jurnal Neuroanestesi Indonesia"},{"key":"3180_CR27","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/01.sa.0000422039.22134.87","volume":"56","author":"LT Goodnough","year":"2012","unstructured":"Goodnough LT, Shander A (2012) Patient blood management. Surv Anesthesiology 56:278\u2013279. https:\/\/doi.org\/10.1097\/01.sa.0000422039.22134.87","journal-title":"Surv Anesthesiology"},{"key":"3180_CR28","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1124\/jpet.301.1.168","volume":"301","author":"R Furtm\u00fcller","year":"2002","unstructured":"Furtm\u00fcller R, Schlag MG, Berger M et al (2002) Tranexamic acid, a widely used Antifibrinolytic Agent, causes convulsions by a \u03b3-Aminobutyric AcidA receptor antagonistic effect. J Pharmacol Exp Ther 301:168\u2013173. https:\/\/doi.org\/10.1124\/jpet.301.1.168","journal-title":"J Pharmacol Exp Ther"},{"key":"3180_CR29","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.1172\/jci63375","volume":"122","author":"I Lecker","year":"2012","unstructured":"Lecker I, Wang D-S, Romaschin AD et al (2012) Tranexamic acid concentrations associated with human seizures inhibit glycine receptors. J Clin Invest 122:4654\u20134666. https:\/\/doi.org\/10.1172\/jci63375","journal-title":"J Clin Invest"},{"key":"3180_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/nan.12459","volume":"44","author":"TJ Stone","year":"2018","unstructured":"Stone TJ, Rowell R, Jayasekera BAP et al (2018) Review: molecular characteristics of long-term epilepsy\u2010associated tumours (LEATs) and mechanisms for tumour\u2010related epilepsy (TRE). Neuropathol Appl Neurobiol 44:56\u201369. https:\/\/doi.org\/10.1111\/nan.12459","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3180_CR31","doi-asserted-by":"crossref","unstructured":"Adhikari S, Walker BC, Mittal S (2021) Pathogenesis and Management of Brain Tumor-Related Epilepsy. In: Gliomas. Exon Publications. 199\u2013210","DOI":"10.36255\/exonpublications.gliomas.2021.chapter12"},{"key":"3180_CR32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/ta.0000000000002061","volume":"86","author":"SP Myers","year":"2019","unstructured":"Myers SP, Kutcher ME, Rosengart MR et al (2019) Tranexamic acid administration is associated with an increased risk of posttraumatic venous thromboembolism. J Trauma Acute Care Surg 86:20\u201327. https:\/\/doi.org\/10.1097\/ta.0000000000002061","journal-title":"J Trauma Acute Care Surg"},{"key":"3180_CR33","doi-asserted-by":"publisher","first-page":"e210884","DOI":"10.1001\/jamasurg.2021.0884","volume":"156","author":"I Taeuber","year":"2021","unstructured":"Taeuber I, Weibel S, Herrmann E et al (2021) Association of Intravenous Tranexamic Acid with thromboembolic events and mortality. JAMA Surg 156:e210884. https:\/\/doi.org\/10.1001\/jamasurg.2021.0884","journal-title":"JAMA Surg"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-03180-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-025-03180-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-03180-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T04:17:45Z","timestamp":1772079465000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-025-03180-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3180"],"URL":"https:\/\/doi.org\/10.1007\/s10143-025-03180-2","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,6]]},"assertion":[{"value":"6 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}